Indivior (LON:INDV) Stock Price Passes Below Two Hundred Day Moving Average of $1,378.27

Indivior PLC (LON:INDV)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,378.27 ($17.73) and traded as low as GBX 992.57 ($12.77). Indivior shares last traded at GBX 1,047 ($13.47), with a volume of 684,636 shares trading hands.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft dropped their price objective on Indivior from GBX 2,350 ($30.23) to GBX 1,500 ($19.30) and set a “buy” rating for the company in a research note on Tuesday, July 9th.

Indivior Price Performance

The business has a 50 day moving average of GBX 1,141.72 and a 200 day moving average of GBX 1,379.30. The company has a market cap of £1.41 billion, a PE ratio of 34,900.00, a price-to-earnings-growth ratio of -5.57 and a beta of 0.06. The company has a debt-to-equity ratio of 2,790.00, a current ratio of 0.93 and a quick ratio of 1.52.

Insider Buying and Selling

In other Indivior news, insider Jo Le Couilliard purchased 1,490 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was bought at an average price of GBX 1,006 ($12.94) per share, with a total value of £14,989.40 ($19,281.45). 3.25% of the stock is currently owned by insiders.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.